Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Examining the Impact of Nicotine Pouches in Rural Ohio and Ohio Appalachia
NCT05730439Phase 1Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- May 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine in carcinoma (6 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Plasma nicotine delivery up to 2 years, Behavioral intentions up to 2 years and 3 more. Started May 2023; status: completed.
02
Drugs
nicotine
03
Conditions
carcinoma
Beyond the preview
Go deeper on NCT05730439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05730439.